Market Research Life Sciences Pharmaceuticals Generics Drugs

Generics in Australia - Market Summary, Competitive Analysis and Forecast to 2025

Lowest Prices Guaranteed Length Publisher Published Date SKU
from $350 41 Pages MarketLine July, 2021 MTLN16740496
Lowest Prices Guaranteed
Price from $350
Length 41 Pages
Publisher MarketLine
Published Date July, 2021
SKU MTLN16740496

Generics in Australia - Market Summary, Competitive Analysis and Forecast to 2025

Summary

Generics in Australia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

  • For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
  • The Australian generics market had total revenues of $1.3bn in 2020, representing a compound annual growth rate (CAGR) of 3.6% between 2016 and 2020.
  • Market consumption volume increased with a CAGR of 5.5% between 2016 and 2020, to reach a total of 66.8% in 2020.
  • The Australian government has undertaken cost containment measures in the pharmaceuticals market due to the growing and aging population, which has resulted in an increasing demand for generic medicines.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in Australia
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Australia
  • Leading company profiles reveal details of key generics market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Australia generics market with five year forecasts
Reasons to Buy
  • What was the size of the Australia generics market by value in 2020?
  • What will be the size of the Australia generics market in 2025?
  • What factors are affecting the strength of competition in the Australia generics market?
  • How has the market performed over the last five years?
  • What are the main segments that make up Australia's generics market?


1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths/weaknesses of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How has the COVID-19 pandemic impacted leading players?
8 Company Profiles
8.1. Teva Pharmaceutical Industries Limited
8.2. Viatris Inc.
8.3. Aspen Pharmacare Holdings Ltd
8.4. Lupin Ltd
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. About MarketLine
List of Tables
Table 1: Australia generics market value: $ million, 2016-20
Table 2: Australia generics market volume: %, 2016-20
Table 3: Australia generics market geography segmentation: $ million, 2020
Table 4: Australia generics market value forecast: $ million, 2020-25
Table 5: Australia generics market volume forecast: %, 2020-25
Table 6: Teva Pharmaceutical Industries Limited: key facts
Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Limited: Key Employees
Table 9: Viatris Inc.: key facts
Table 10: Viatris Inc.: Annual Financial Ratios
Table 11: Viatris Inc.: Key Employees
Table 12: Aspen Pharmacare Holdings Ltd: key facts
Table 13: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 14: Aspen Pharmacare Holdings Ltd: Key Employees
Table 15: Lupin Ltd: key facts
Table 16: Lupin Ltd: Annual Financial Ratios
Table 17: Lupin Ltd: Key Employees
Table 18: Lupin Ltd: Key Employees Continued
Table 19: Australia size of population (million), 2016-20
Table 20: Australia gdp (constant 2005 prices, $ billion), 2016-20
Table 21: Australia gdp (current prices, $ billion), 2016-20
Table 22: Australia inflation, 2016-20
Table 23: Australia consumer price index (absolute), 2016-20
Table 24: Australia exchange rate, 2016-20
List of Figures
Figure 1: Australia generics market value: $ million, 2016-20
Figure 2: Australia generics market volume: %, 2016-20
Figure 3: Australia generics market geography segmentation: % share, by value, 2020
Figure 4: Australia generics market value forecast: $ million, 2020-25
Figure 5: Australia generics market volume forecast: %, 2020-25
Figure 6: Forces driving competition in the generics market in Australia, 2020
Figure 7: Drivers of buyer power in the generics market in Australia, 2020
Figure 8: Drivers of supplier power in the generics market in Australia, 2020
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Australia, 2020
Figure 10: Factors influencing the threat of substitutes in the generics market in Australia, 2020
Figure 11: Drivers of degree of rivalry in the generics market in Australia, 2020

$350
$700
$1,050

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings